Introduction
Extensive evidence from genetics, genomics and cell biology demonstrated that cancer onset and progression is not only determined by tumor cells but is also influenced by the microenvironment (1) (2) (3) . Microenvironment is a complex system which largely consists of extracellular matrix (ECM) proteins and proteoglycans, soluble factors and small signaling molecules such as cytokines and chemokines, along with a variety of cell types such as fibroblasts, immune cells and endothelial cells. Under normal conditions, the microenvironment constitutes an important modulator of epithelium cell fate and a barrier to cell transformation (4) . Dynamic communications between the epithelium and the microenvironment notably modulate cell growth, apoptosis, and maintain epithelial cell polarity and differentiation (4) . In cancer, the microenvironment which is also referred to as stroma, experiences drastic changes, including the recruitment and the activation of stromal cells and the remodeling of ECM.
Importantly, co-evolution of tumor cells with their microenvironment during tumorigenesis suggests that tumor-stroma crosstalk may likely influence the phenotype of tumor cells and may provide a selective pressure for tumor initiation, progression and metastasis (1, 5, 6) .
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver.
The incidence of HCC is rising in many countries and its prognosis is typically poor.
Thus, with 550,000 cases newly diagnosed and 600,000 deaths annually, HCC ranks among the deadliest forms of human malignancies worldwide (7) . The remodeling of liver microenvironment is a hallmark of HCC pathogenesis (8) . Indeed, more than 80% HCC develop in the setting of chronic hepatitis, fibrosis and cirrhosis, conditions in 6 which inflammation and ECM deposition profoundly alter the hepatic microenvironment (9) . However, the functional impact of the disrupted microenvironment on hepatocyte biology remains poorly understood (10) . Over the last decade, high-throughput genomic studies provided important insights to classify HCC at a molecular level and to identify deregulated gene networks and signaling pathways (11) . However, most of gene expression signatures in HCC have been derived from whole tumor tissues consisting of both the cancer epithelial cells and their surrounding microenvironment, a strategy which rendered elusive to evaluate the specific contribution of each compartment.
Activation of hepatic stellate cells (HSC) is a key feature of liver fibrosis and cirrhosis (12) . Following liver injury, quiescent HSC become activated and convert into highly proliferative myofibroblast-like cells which express inflammatory and fibrogenic mediators responsible for ECM accumulation within microenvironment (12, 13) .
Therefore, the present study was specifically designed to address the functional impact and the clinical relevance of the crosstalk between tumor hepatocytes and activated HSC. By using a coculture model system, genome-wide expression profiling and functional assays we demonstrated that the crosstalk between hepatocytes and activated HSC i) is bidirectional; ii) induces an alteration of hepatocyte phenotype toward migration; iii) generates a permissive pro-inflammatory and pro-angiogenic microenvironment; iv) is predictive of a poor prognosis in human HCC; and v) could be targeted by epigenetic modulation.
Materials and Methods
Research. Cell lines and coculture experiments. HepaRG and HuGB cell lines were established in our lab and maintained as previously described (14, 15) . HepaRG cells were grown in William's E medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 5 μg/ml insulin, and 50 µM hydrocortisone hemisuccinate.
Differentiation of HepaRG from progenitors to mature well-differentiated hepatocytes was achieved in 4 weeks by culturing the cells in the supplemented medium in presence of 2% dimethyl sulfoxide (DMSO) for the last 2 weeks as previously described (16) (Supporting Fig. 1A ). All experiments hereinafter referred to as HepaRG were conducted using mature hepatocytes selectively isolated by mild trypsinization from DMSO-treated cultures. LX2 cells (Supporting Fig. 1B) were provided by S.L. Friedman and were maintained in supplemented DMEM medium as described (17) . HepaRG/LX2 cocultures were conducted in serum-and DMSO-free William's E medium using 6-well plates and 1 µm pore size transwell inserts which allow diffusion of media components but prevent cell migration (BD Biosciences, San Jose, CA) (Supporting Fig. 1C ). Huh7 and HepG2 cell lines were obtained from the European Collection of Cell Cultures (ECACC) which performed cell lines authentication by DNA barcoding. Primary human umbilical vein endothelial cells (HUVEC) were purchased from Invitrogen (Carlsbad, CA, USA) and were maintained in 200PRF medium supplemented with a low serum growth supplement (LSGS). All cell cultures were performed at 37°C in a 5% CO 2 atmosphere. Trichostatin A was purchased from Sigma-Aldrich (St. Louis, MO, USA).
Independent culture experiments were performed at least in triplicate.
Microarray analysis. Total RNA was purified from cells at 80% confluence with a RNAeasy kit (Qiagen, Valencia, CA, USA). Genome-wide expression profiling was 8 performed using the low-input QuickAmp labeling kit and human SurePrint G3 8x60K pangenomic microarrays (Agilent Technologies, Santa Clara, CA, USA) as previously described (18) . Starting from 150 ng total RNA, amplification yield was 9.7±0.6 μg cRNA and specific activity was 20.3±1.3 pmol Cy3 per μg cRNA. Gene expression data were processed using Feature Extraction and GeneSpring softwares (Agilent Technologies) and further analyzed using R-based BRB-ArrayTools. Briefly, differentially expressed genes were identified by a two-sample univariate t-test and a random variance model (P<0.01; false discovery rate <1%) as described (19) . Permutation P-values for significant genes were computed based on 10,000 random permutations. Class prediction was performed using 7 algorithms and misclassification rate was computed using a leave-one-out cross-validation method (20) . Clustering analysis was done using Cluster 3.0 and TreeView 1.6 using uncentered correlation and average linkage options. MIAME compliant microarray data have been deposited into gene expression omnibus (GEO) database (GSE32565).
Data mining and integrative genomics. Gene annotation was based on gene ontology and enrichment for specific biological functions or canonical pathways was evaluated using FuncAssociate 2.0 program (21) . Ingenuity pathway analysis (IPA) was used to examine the functional association between differentially expressed genes and to generate the highest significant gene networks (Mountain View, CA, USA). Relevant networks were identified using the scoring system provided by IPA. Gene set enrichment analysis (GSEA) was performed by using the Java-tool developed at the Broad Institute (Cambridge, MA, USA) as previously described (22) . Unsupervised GSEA was done with the whole C2 collection of curated gene sets from the molecular (23) . Integration of genomic data was performed as previously described (20) using publicly available gene expression datasets downloaded from GEO.
Real time RT-PCR. Expression of relevant genes was measured by quantitative real time PCR as previously described (22) . Quantitative analysis of PCR data was performed with the 2 −ΔΔCt method using GAPDH Ct values for normalization. Melting analysis was conducted to validate the specificity of PCR products. PCR and microarray analysis were performed using RNA extracted from independent culture experiments (n=3). Gel zymography. MMP activity in CM was evaluated in triplicate by gelatine zymography as described (8) . Recombinant human MMP2 and MMP9 were used as positive controls. After scanning, images were analyzed by densitometry using ImageJ (NIH, Bethesda, USA).
Statistical analysis.
Quantitative results were expressed as mean and SD and the significance was evaluated by Student's t-test. Table 1 ). More than 83% genes were up-regulated suggesting that coculture with LX2 induced a global shift toward transcriptional activation in HepaRG (Fig. 1A) . In LX2, the expression of 123 genes was significantly altered by the coculture condition ( analysis of genes differentially expressed in coculture vs culture condition revealed a bidirectional crosstalk between HepaRG and LX2.
Results

Coculturing
Coculture with LX2 induces an inflammatory response and a motile phenotype in
HepaRG. Gene ontology and ingenuity analysis showed that the genes related to cell chemotaxis, motility and inflammation were significantly enriched in the HepaRG/LX2 signature (Supporting Table 3 ). Notably, several important pro-inflammatory and profibrogenic cytokines (e.g. IL1B, IL6, IL8), acute phase proteins (e.g. CP, SAA1), and growth factors (e.g. AREG, EREG) were up-regulated in HepaRG when the two cell types were cultured together ( Fig. 1A and Supporting Table 1 ). Accordingly, a wellorganized gene network linked to IL1B, IL6, IL8 and CCL2, which is also known as the monocyte chemoattractant protein 1 (MCP1) was identified by IPA ( Fig. 2A and Supporting Fig. 3 ). The expression of IL6, IL8 and CCL2 was further evaluated by Q-RT-PCR using RNA extracted from independent cell culture experiments. As shown in Fig. 2B , all genes were significantly up-regulated in HepaRG after 48 hrs coculture with LX2. Together these data suggested that the crosstalk between HepaRG and LX2 resulted in the establishment of a pro-inflammatory microenvironment. To validate this observation, we performed a GSEA using an independent gene set which covered the whole response of Hep3B-hepatocytes to pro-inflammatory cytokines (25) . This approach unambiguously demonstrated that coculture with LX2 induced a prominent inflammatory response in HepaRG (Fig. 2C) . Inflammation is thought to play a key role in cancer initiation and progression by fostering multiple hallmarks of cancer including tumor cell proliferation and motility (1) . To evaluate whether the coculture condition had any impact on the phenotype of HepaRG, mature hepatocytes were isolated from new (Fig. 4C) . Absence of tube formation was also noticed when HUVEC were exposed to CM derived from HepaRG cultured alone (data not shown). Next, MMP activity in CM was evaluated by 
gelatin zymography. In agreement with the increased expression of MMP9 (Fig. 4B) , we showed that MMP9 activity was significantly higher (P<0.01) in LX2/HepaRG-CM than in LX2-CM (Fig. 4D) . Similar observation was made for MMP2. These data suggested that hepatocyte-HSC crosstalk resulted in the establishment of a permissive proangiogenic microenvironment which may facilitate the migration of tumor cells. cases of human HCC which were extensively characterized (20, (26) (27) (28) . Hierarchical clustering analysis of the integrated dataset identified two robust clusters which organization was driven by the culture condition of HepaRG: cluster 1, HepaRG/LX2 coculture; cluster 2, HepaRG culture (Fig. 5A) . Interestingly, we observed that clinical and biological parameters of HCC were not randomly distributed between the clusters 1 and 2. Strikingly, cluster 1 included significantly more tumors which were previously assigned to a poor prognosis group than cluster 2 (Fig. 5A ). As shown in Fig. 5B , cluster 1 HCC were previously defined by a bad survival (27) , hepatoblast traits (28), along with the activation of oncogenic MET/HGF (26) and TGFβ pathways (20) . In addition, they exhibited a poorly differentiated phenotype (Edmondson grade >3), signs of vascular invasion and were significantly bigger in size (Fig. 5B) 
HepaRG
poor prognosis when evaluated as a unique gene set, we also reported that 85% of genes included in the signature and expressed in primary HCC were clinically relevant when analyzed individually (Supporting Table 4 ). Unsupervised GSEA further supported the relevance of HepaRG/LX2 signature in predicting a poor prognosis phenotype, not only in HCC but also in other cancers. In the context of HCC, we found that specific signatures for recurrence (29), c-Myc/Tgfα aggressive mouse model of HCC (30) or TGFβ (20) were significantly enriched in the HepaRG/LX2 gene profiles (Supporting Table 5 ). This approach also demonstrated that gene signatures associated with a bad prognosis in cancers other than HCC (e.g. invasive breast cancer, advanced gastric cancer, metastatic stromal cells, and highly metastatic pancreatic cancer cells) were significantly (P<0.01) enriched both in HepaRG and LX2 under coculture conditions (Supporting Fig. 4) . To further investigate the relevance of the HepaRG/LX2 crosstalk signature in HCC progression, we performed a cross-species integrative genomic approach as described previously (20) . progression in transgenic mice, ranging from 3 weeks (moderate dysplasia), 3 months (severe dysplasia) and 9 months (HCC) (30) . By using a multidimensional scaling approach, we demonstrated that the HepaRG/LX2 signature effectively discriminated the mouse samples based on HCC progression (Supporting Fig. 5B ).
Because HSC activation is an early event in the pathogenesis of HCC, we asked whether the HepaRG/LX2 signature within cirrhosis tissues from patients with HCC could predict any specific clinical outcome. To test this hypothesis, we used a publicly available gene expression dataset established from the noncancerous hepatic tissue of patients with primary HCC (GSE5093 in GEO database). In this cohort, patients were divided in two groups based on the presence or absence of venous metastasis (31).
Accordingly, cirrhosis tissues isolated from patients with or without metastasis were respectively termed metastasis-inclined microenvironment (MIM) and metastasis-averse microenvironment (MAM) (31) . Based on the HepaRG/LX2 signature, we showed that MIM and MAM samples coclustered with HepaRG/LX2 and HepaRG samples respectively (Fig. 5C ). GSEA confirmed that the genes which signed the crosstalk between HepaRG and LX2 were significantly enriched in the expression profiles of cirrhosis tissue from patients with metastasis (Fig. 5C) . Altogether, these results demonstrated that the expression of genes embedded in the HepaRG/LX2 signature, either in cirrhosis or in HCC, was predictive of a poor prognosis and was associated with metastasis propensity. Table 6 ). TSA was chosen for further experiments on the basis of the higher number of hits obtained with connectivity map (n=182 hits, Fig. 6A ) and the results of the unsupervised GSEA which demonstrated that genes silenced by TSA in pancreatic cancer were significantly (P<0.01) enriched in the gene profiles of both HepaRG and LX2 under coculture conditions (Supporting Fig. 4 ). To test whether TSA could modulate the HepaRG/LX2 crosstalk, we produced CM from culture and coculture of HepaRG and LX2 cells exposed to 500nM TSA or DMSO control. As shown in Fig.   6B , the migration of freshly isolated HepaRG-hepatocytes in response to HepaRG/LX2-CM was completely abrogated in presence of TSA. We further showed in HepaRG that LX2-induced up-regulation of amphiregulin and epiregulin, two genes which have been linked to invasion and metastasis, was abolished by TSA (Supporting Fig. 6A ). Our data also suggested that TSA was able to inhibit coculture-induced angiogenesis as evidenced by the absence of tube formation by endothelial cells and the reduced VEGFA expression by LX2 cells under coculture condition (Supporting Fig. 6B ).
Discussion
The tumor microenvironment contributes in the acquisition of multiple hallmarks of cancer (1) . However, the underlying molecular mechanisms involved in the interactions between the tumor cells and the microenvironment remain poorly and activated HSC, consistent with previous observations (32, 33) . Inflammatory cells and mediators are frequent in the local environment of tumors and several lines of evidences suggested that inflammation contributes to the acquisition of core hallmark capabilities in cancer (1) . Notably, epidemiological studies suggested that inflammatory diseases predispose individuals to cancer (34) . Thus, an increase expression of IL6 was reported in the serum of most cancer patients. In HCC, IL6 expression was found to correlate with a rapid progression from hepatitis to HCC (35) , and an activation of IL6 pathway was reported in HCC with a poor prognosis (36) . The invasive capacity of malignant cells has been shown to be increased in presence of IL1B and IL6 (34) .
Recently, somatic alterations of gp130 and STAT3, which are required for IL6 signaling, have been reported in inflammatory hepatocellular adenomas (37, 38) . 
Consistent with previous observations using human or rat HSC (32, 33) , our results also demonstrate that hepatocyte-HSC crosstalk may greatly impact the local tumor microenvironment, particularly ECM turnover by MMPs and angiogenesis, two main mechanisms promoting tumor growth and metastasis. Previously, we have shown that hepatocyte-HSC interplays induces enhanced extracellular matrix remodeling though MMP2 activation (41) . In the present study, in addition to the increased expression of VEGF and MMPs, we report that the enhanced expression of 
